DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Small Molecule Drugs cited in UCB, Inc. v. Actavis Laboratories UT, Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2020-09-16||135||Opinion - Memorandum Opinion||claims of U.S. Patent No. 10,130,589 (the "'589 Patent"), the patent asserted by the…parties regarding related patents, U.S. Patent Nos. 6,884,434 (the "'434 Patent") and 8,232,…quot;'414 Patent"), and held the '414 Patent invalid and the '434 Patent valid and infringed…Orange Book patents related to Neupro® to determine whether any of them were 'blocking patents[,]"…and fourth, UCB's other patents did not function as blocking patents. (D.I. 110 at 4-5.)||External link to document|
|2020-02-06||80||Opinion - Memorandum Opinion||infringement of U.S. Patent No. 10,130,589 (the "' 589 Patent"). (D.I. 1) The patent-in-suit relates…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id at 1321 (internal quotation marks omitted). The patent "specification…of the ' 589 patent, and, thus, should be limiting. See, e.g., ' 589 patent at 3:12-36, 5:22-…preamble term was not relied on during patent prosecution as being patentably significant or to distinguish||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|